Data from the longitudinal ColoCare study (NCT02328677) of patients with colorectal cancer add to a growing body of evidence ...

Two new studies report worse colorectal cancer survival among patients with lower socioeconomic status, adding weight to a ...

Staying physically active, especially through regular walking, may help reduce cancer-related fatigue and improve quality of ...

Frequent dining out is linked to a higher risk of colorectal cancer, with a dose-response relationship observed. Obesity partially mediates the association between dining out frequency and colorectal ...

A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, ...

Our Care Advisors will connect you with the best healthcare provider for your needs. MSK is a leader in cancer clinical trials. We often have many trials at a time, researching different types of ...

A recent study shows that bacteria living inside colorectal tumors form distinct ecosystems that are closely linked to how ...

The latest edition of an annual report finds new cases continue to rise and outcomes have worsened for some cancers.

GLP-1 drugs are 36% more effective than aspirin in reducing colorectal cancer risk, with fewer side effects like acute kidney ...

Researchers from Vanderbilt University Medical Center have demonstrated in a precision-based clinical trial that a magnesium ...

In BREAKWATER, EC plus FOLFIRI achieved a 64.4% response rate and showed a trend toward improved overall survival in patients ...

Benefits of GLP-1 RAs were consistent across age groups and BMI categories, with semaglutide showing significant efficacy. These results were presented during the press briefing ahead of the 2026 ...